Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jens Overgaard, Ludvig Paul Muren, Morten Høyer & Cai Grau. (2019) BIGART 2019 – adapting to the future. Acta Oncologica 58:10, pages 1323-1327.
Read now
Read now
Articles from other publishers (7)
Hamid A. Bakshi, Michella Mkhael, Hakkim L. Faruck, Asad Ullah Khan, Alaa A.A. Aljabali, Vijay Mishra, Mohamed El-Tanani, Nitin B. Charbe & Murtaza M. Tambuwala. (2024) Cellular signaling in the hypoxic cancer microenvironment: Implications for drug resistance and therapeutic targeting. Cellular Signalling 113, pages 110911.
Crossref
Crossref
Kerong Guo, Xin Ma, Jian Li, Chong Zhang & Liqiang Wu. (2022) Recent advances in combretastatin A-4 codrugs for cancer therapy. European Journal of Medicinal Chemistry 241, pages 114660.
Crossref
Crossref
Li Liu, Regan Schuetze, Jeni L. Gerberich, Ramona Lopez, Samuel O. Odutola, Rajendra P. Tanpure, Amanda K. Charlton-Sevcik, Justin K. Tidmore, Emily A.-S. Taylor, Payal Kapur, Hans Hammers, Mary Lynn Trawick, Kevin G. Pinney & Ralph P. Mason. (2022) Demonstrating Tumor Vascular Disrupting Activity of the Small-Molecule Dihydronaphthalene Tubulin-Binding Agent OXi6196 as a Potential Therapeutic for Cancer Treatment. Cancers 14:17, pages 4208.
Crossref
Crossref
Li Liu, Devin O’Kelly, Regan Schuetze, Graham Carlson, Heling Zhou, Mary Lynn Trawick, Kevin G. Pinney & Ralph P. Mason. (2021) Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors. Molecules 26:9, pages 2551.
Crossref
Crossref
Ryszard Smolarczyk, Justyna Czapla, Magdalena Jarosz-Biej, Kyle Czerwinski & Tomasz Cichoń. (2021) Vascular disrupting agents in cancer therapy. European Journal of Pharmacology 891, pages 173692.
Crossref
Crossref
Stefania Zuppone, Andrea Bresolin, Antonello E. Spinelli, Giuseppe Fallara, Roberta Lucianò, Federico Scarfò, Fabio Benigni, Nadia Di Muzio, Claudio Fiorino, Alberto Briganti, Andrea Salonia, Francesco Montorsi, Riccardo Vago & Cesare Cozzarini. (2020) Pre-clinical Research on Bladder Toxicity After Radiotherapy for Pelvic Cancers: State-of-the Art and Challenges. Frontiers in Oncology 10.
Crossref
Crossref
Michael R. Horsman, Thomas R. Wittenborn, Patricia S. Nielsen & Pernille B. Elming. (2020) Tumors Resistant to Checkpoint Inhibitors Can Become Sensitive after Treatment with Vascular Disrupting Agents. International Journal of Molecular Sciences 21:13, pages 4778.
Crossref
Crossref